Fact Check: Kamala Harris Claims Administration Capped Insulin Costs for Seniors
Vice President Kamala Harris claimed that President Joe Biden and her administration “finally” capped the cost of insulin for seniors.
Vice President Kamala Harris claimed that President Joe Biden and her administration “finally” capped the cost of insulin for seniors.
CLAIM: The Biden-Harris administration capped the cost of insulin, Vice President Kamala Harris said during Friday’s economic speech.
CLAIM: President Joe Biden claimed during Thursday’s State of the Union address that he capped the cost of insulin.
Danish pharmaceutical company Novo Nordisk has announced that it will lower the price of some of its insulin products in the United States by up to 75 percent, effective January 1, 2024.
Pharmaceutical giant Eli Lilly has announced it is instituting a $35 dollar monthly cap on out-of-pocket insulin expenses.
President Joe Biden claimed during Tuesday’s State of the Union that the Democrats’ Inflation Reduction Act put a monthly cap of $35 on insulin costs for Medicare enrollees.
Vulnerable Ohio Democrat Rep. Marcy Kaptur released a campaign ad this month touting her work to lower healthcare costs, but the specific legislation the congresswoman cited has not helped lower anything since it has not been signed into law.
The Senate parliamentarian removed a $35 insulin cap and Senate Democrats failed to reincorporate the measure into the Inflation Reduction Act.
A British aid worker detained by pro-Russia separatists in Ukraine has died in captivity, a separatist official said Friday.
The House will soon vote on a Democrat bill that would cap the price of insulin, which is viewed by Republicans as a cynical ploy to boost Sen. Raphael Warnock’s (D-GA) reelection chances.
President Joe Biden told Congress Tuesday evening in his State of the Union address to pass legislation to lower insulin prices — after he suspended, and then rescinded, former President Donald Trump’s executive order to lower them.
President Joe Biden’s first actions included a directive that suspends President Donald Trump’s executive order aimed at lowering the prices of insulin and epinephrine, which was to have gone into effect on Friday, January 22.
President Donald Trump announced Tuesday a plan that would drastically lower the cost of insulin for Medicare enrollees to $35 a month.
Trump announced new Medicare plans on Tuesday to provide diabetic seniors with low-cost insulin. The administration estimates that the new plans would reduce insulin costs by 66 percent.
John Longworth, the Director-General of the British Chambers of Commerce turned Brexit Party MEP, has hailed a guarantee from Britain’s biggest insulin supplier that there will be no shortages of the medication if the country makes a clean, no-deal break with the European Union at the end of October.